ONGLYZA 5 mg/1

Onglyza 5 mg tablets contain saxagliptin, a DPP-4 inhibitor used to manage type 2 diabetes. This oral medication helps regulate blood sugar levels when combined with diet and exercise.

Onglyza is primarily used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Saxagliptin works by increasing insulin levels and decreasing glucose production in the liver. It is often prescribed for individuals who have not achieved adequate blood sugar control through lifestyle modifications alone.

Common effects of Onglyza may include headache, upper respiratory tract infection, and nasopharyngitis. Some users might experience gastrointestinal discomfort or mild allergic reactions. These effects vary among individuals and are not exhaustive.

Onglyza should be handled with care, especially by individuals with a history of pancreatitis, kidney issues, or allergic reactions to DPP-4 inhibitors. It is important to consult a healthcare provider before starting this medication, particularly if you have other medical conditions or are taking other medications.

Onglyza may interact with certain medications, including those metabolized by the liver's CYP3A4/5 enzymes. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.